Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose oral interferon alpha lozenges for prevention of winter cold and flu symptoms
ACTRN12609000976280Phase 2Recruiting
- Sponsor
- Sir Charles Gairdner Hospital
- Start
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of piroxicam in influenza and nasopharyngitis (2 arms), sponsored by Sir Charles Gairdner Hospital. Primary endpoint: Frequency and severity of winter cold and flu-like symptoms. Started May 2009; status: recruiting.
02
Drugs
piroxicam
03
Conditions
influenzanasopharyngitis
Beyond the preview
Go deeper on ACTRN12609000976280.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12609000976280.